The earnings collapse and restatement signal deteriorating fundamentals despite a high cash balance. Traders should watch for further guidance on the rabies vaccine launch and resolution of the 2018 PIPE share litigation, which could impact the dividend payable and share count.
Price Chart
Executive Summary
Sinovac reported flat revenue of $130.3M for H1 2025, but swung from a $93.9M profit to a $21.7M net loss, driven by $68.1M in IPR&D/goodwill impairments and reduced investment income. The company also restated prior-period financials and declared a $4.0B special dividend, masking underlying operational weakness.
Key Facts
- Revenue nearly flat at $130.3M (+1.2% YoY)
- Net loss attributable to common shareholders of $21.7M vs net income of $93.9M in H1 2024
- Impairment of $68.1M in IPR&D and goodwill related to rabies vaccine subsidiary
- Restatement of prior-period financial statements (Non-Reliance on previously issued numbers)
- Declared a special cash dividend of $55.00 per share totaling $4.0B, with $3.3B paid
Financial Impact
Earnings collapsed from $93.9M net income to $21.7M net loss; impairments totaled $68.1M; special dividend of $4.0B declared
Risk Factors
- Further impairments from delayed vaccine launches
- Litigation over 2018 PIPE shares may affect capital structure
- Restatement raises credibility concerns with investors
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-054027 |
| Document: ea0289810-6k_sinovac.htm | 0001213900-26-054027 |
| Document: 0001213900-26-054027-index-headers.html | 0001213900-26-054027 |
| Document: 0001213900-26-054027-index.html | 0001213900-26-054027 |
| Document: 0001213900-26-054027.txt | 0001213900-26-054027 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 10w ago | 6-K | — | awaiting T+5 | — | — |
Jul 15, 2026 14w ago | 6-K | — | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −2.62% | — |
Jun 5, 2026 20w ago | 20-F | $6.47 $6.47 | · 0.00% | ▲ +0.57% | — |
May 29, 2026 21w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −2.75% | — |
May 21, 2026 22w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −1.85% | — |
May 8, 2026 24w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −0.09% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers